Product Description
Overall, India’s Dental Bone Graft Substitute and other biomaterials market was valued at nearly $44 million in 2023. This is expected to increase over the forecast period at a CAGR of 14.9% to reach almost $116 million.
The full report suite on the Indian market for dental bone graft substitutes (DBGSs) and other biomaterials includes DBGSs, dental barrier membranes and local antimicrobial periodontal treatments. Collectively, these segments will be referred to as the dental biomaterials market.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2030, and Historical Data to 2020
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
INDIA DENTAL BONE GRAFT SUBSTITUTES MARKET TRENDS
MARKET SEGMENTATION SUMMARY
- Dental Bone Graft Substitute (DBGS) Market – The market analysis is further broken down into segments by:
- Type: Mineralized Allografts, Demineralized Bone Matrix (DBM) Allografts, Xenografts, Synthetics.
- Application*: Socket Preservation, Sinus Augmentation, Ridge Augmentation, Periodontal Procedure.
- Dental Barrier Membrane Market – The market analysis is further broken down into segments by:
- Material: Allografts, Xenografts (Bovine, Porcine), Synthetics.
- Type: Resorbable (Small, Medium, Large), Non-Resorbable (Small, Large (Non-Reinforced, Titanium-Reinforced))
- Antimicrobial Periodontal Treatment Market
*Segment is analyzed at a unit level only.
Research Scope Summary
Report Attribute | Details |
---|---|
Region | Asia Pacific (India) |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2022 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |